当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析

同和药业

(300636)

  

流通市值:33.80亿  总市值:38.64亿
流通股本:3.67亿   总股本:4.20亿

同和药业(300636)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.58亿元,每股收益0.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益235062.97万元,未分配利润61713.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产326848.43万元,负债91785.46万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入427,422,152.61186,897,547.53758,890,499.03569,933,408.38
营业总成本341,667,938.34161,677,017.83626,890,162.6455,177,777.45
其他经营收益
营业利润64,581,581.9722,045,134.74111,400,839.04106,011,166.69
利润总额64,581,632.9922,045,185.76114,689,908.16105,498,257.33
净利润58,486,512.5720,781,376.97106,584,102.1795,736,461.6
每股收益
其他综合收益----
综合收益总额58,486,512.5720,781,376.97106,584,102.1795,736,461.6
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,239,075,084.931,164,235,983.151,051,029,837.06995,438,366.73
非流动资产:
非流动资产合计2,029,409,249.592,257,051,203.282,268,521,835.652,299,646,480.15
资产总计3,268,484,334.523,421,287,186.433,319,551,672.713,295,084,846.88
流动负债:
流动负债合计411,224,471.07587,760,063.24505,841,421.41536,381,037.93
非流动负债:
非流动负债合计506,630,136.6503,997,860.39504,962,365.47449,338,342.76
负债合计917,854,607.671,091,757,923.631,010,803,786.88985,719,380.69
所有者权益(或股东权益):
归属于母公司股东权益合计2,350,629,726.852,329,529,262.82,308,747,885.832,309,365,466.19
股东权益合计2,350,629,726.852,329,529,262.82,308,747,885.832,309,365,466.19
负债和股东权益合计3,268,484,334.523,421,287,186.433,319,551,672.713,295,084,846.88
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计420,756,510.11180,880,374.54884,393,804.35521,186,224.17
经营活动现金流出小计292,940,802.88145,216,119.32599,204,109.96359,022,399.92
经营活动产生的现金流量净额127,815,707.2335,664,255.22285,189,694.39162,163,824.25
投资活动产生的现金流量:
投资活动现金流入小计366,493,335.3283,354,339.0977,846,960.0360,297,427
投资活动现金流出小计196,032,228.4467,264,490.43583,499,893.25521,271,504.37
投资活动产生的现金流量净额170,461,106.8816,089,848.66-505,652,933.22-460,974,077.37
筹资活动产生的现金流量:
筹资活动现金流入小计232,580,000164,580,000891,487,338.8658,487,338.8
筹资活动现金流出小计338,975,044.7985,871,770.281,002,461,092.97740,894,705.77
筹资活动产生的现金流量净额-106,395,044.7978,708,229.72-110,973,754.17-82,407,366.97
汇率变动对现金及现金等价物的影响1,613,697.98339,655.944,046,855.024,760,520.45
现金及现金等价物净增加额193,495,467.3130,801,989.54-327,390,137.98-376,457,099.64
期末现金及现金等价物余额358,907,705.06296,214,227.3165,412,237.76116,345,276.1
补充资料:
现金及现金等价物的净增加额193,495,467.3--327,390,137.98-
最新报告期:2025-08-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫,乔露阳0.310.380.472025-08-29
TOP↑